Workflow
CH INNOVATION(01217)
icon
Search documents
中国创新投资(01217) - 2022 - 年度业绩
2023-03-24 14:54
香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容 概不負責,對其準確性或完整性亦不發表任何聲明,並明確表示概不就 因本公佈全部或任何部分內容而產生或因倚賴該等內容而引致之任何損 失承擔任何責任。 CHINA INNOVATION INVESTMENT LIMITED 中 國 創 新 投 資 有 限 公 司 (於開曼群島註冊成立之有限公司) (股份代號:1217) 二 零 二 二 年 全 年 業 績 公 佈 中國創新投資有限公司(「本公司」)董事謹此宣佈本公司截至二零二二年 十二月三十一日止年度之經審核全年業績如下: 業績 截 至 二 零 二 二 年 十 二 月 三 十 一 日 止 年 度 之 出 售 投 資 所 得 款 項 總 額 約 為 451,249,000港元,而截至二零二一年十二月三十一日止年度之出售投資所 得款項總額則約為544,048,000港元。 截至二零二二年十二月三十一日止年度之出售透過損益按公平值列賬之 投資之已變現收益淨額約10,594,000港元,而二零二一年同期則為出售透 過損益按公平值列賬之投資已變現虧損淨額約52,751,000港元。 ...
中国创新投资(01217) - 2022 - 中期财报
2022-09-01 13:54
Financial Performance - Total proceeds from the sale of securities amounted to HKD 52,569,000 for the six months ended June 30, 2022, a decrease of 78.1% compared to HKD 240,225,000 in the same period of 2021[12]. - Revenue for the six months ended June 30, 2022, was HKD 6,060,000, down 52.5% from HKD 12,791,000 in the same period of 2021[12]. - Profit attributable to owners for the six months ended June 30, 2022, was HKD 2,212,000, a decline of 78.5% compared to HKD 10,265,000 in the same period of 2021[12]. - The basic earnings per share for the six months ended June 30, 2022, was HKD 0.017, compared to HKD 0.080 in the same period of 2021[12]. - Revenue for the six months ended June 30, 2022, was HKD 6,148 million, a decrease of 52% compared to HKD 12,791 million in the same period of 2021[87]. - The bank interest income for the same period was HKD 2 million, down from HKD 22 million in 2021, indicating a significant decline[87]. - The structural product income decreased to HKD 1,560 million from HKD 4,733 million, reflecting a 67% drop year-over-year[87]. - Basic earnings per share were approximately HKD 2,212,000 for the six months ended June 30, 2022, compared to HKD 10,265,000 in 2021[91]. Investment Activities - Investments in five unlisted companies had a combined book value of approximately HKD 236,705,000 as of June 30, 2022[18]. - The company focuses on investment in quality listed and unlisted enterprises, aiming for mid-term capital appreciation through asset securitization[20]. - The company has made significant breakthroughs in five industry sectors: "new energy," "new light sources," "new materials," "new health," and "new capital" through various investments[20]. - The company invested in solar energy technology through Sun Creation Limited, focusing on the development and production of solar cell application products[20]. - Future outlook includes continued exploration of investment opportunities to achieve mid-term capital appreciation[24]. - The company reported unrealized losses of HKD 47,883,000 from its investment in Alibaba Group, with a cost basis of HKD 124,982,000 as of June 30, 2022[28]. Financial Position - As of June 30, 2022, the fair value of listed equity securities held by the company was HKD 147,962,000, compared to HKD 143,157,000 as of December 31, 2021, representing a growth of 5.3%[25]. - The company held structured products valued at HKD 158,622,000 as of June 30, 2022, with a total investment value of HKD 306,584,000, indicating a significant increase from the previous period[25]. - The company's cash and cash equivalents amounted to approximately HKD 10,045,000 as of June 30, 2022, with a zero debt-to-equity ratio, indicating a net cash position[38]. - Total assets as of June 30, 2022, were HKD 613,214 thousand, slightly up from HKD 611,002 thousand as of December 31, 2021[75]. - The company's cash and cash equivalents decreased to HKD 10,045 thousand as of June 30, 2022, from HKD 13,381 thousand at the beginning of the period, representing a decline of 25.5%[81]. - The total net asset value of the company is approximately HKD 613,214,000 as of June 30, 2022, compared to HKD 611,002,000 as of December 31, 2021[121]. Corporate Governance - The company has complied with the corporate governance code, except for the deviation regarding the roles of chairman and CEO being held by the same person[56]. - The executive committee, chaired by Xiang Xin, regularly reviews the company's business performance and operational matters[59]. - The remuneration committee, consisting of three independent non-executive directors, determines the remuneration policy for executive directors[60]. - The nomination committee is responsible for recommending candidates for the board and ensuring the selection of qualified individuals[61]. - The company has established a high level of corporate governance to enhance transparency and protect shareholder interests[56]. Shareholder Information - The company has a 67.75% equity interest in Solar Creation Limited, which focuses on solar cell products, with no dividends received during the period[33]. - The company has a 52.68% equity interest in Lian Guan Future Limited, which is involved in the construction decoration materials business, with no dividends received during the period[36]. - The company holds a 56.84% equity interest in Guangyuan Starry Sky Limited, which is engaged in asset management, with no dividends received during the period[36]. - Harvest Rise Investments Limited holds 3,817,807,905 shares, representing a 29.82% stake in the company[52]. - The company’s chairman and CEO, Xiang Xin, has beneficial interests in 60,394,737 shares, which is approximately 0.47%[49]. - The number of issued and fully paid ordinary shares is 12,801,578,629 as of June 30, 2022, consistent with the figure from December 31, 2021[121]. Employee Compensation - The total compensation paid to employees was approximately HKD 711,000 for the period, an increase from HKD 673,000 in the previous year, reflecting a 5.7% rise in employee remuneration[44]. Risk Management - The company maintained a 0% foreign exchange risk exposure, as it primarily conducts transactions in RMB and HKD, with no significant foreign exchange fluctuations anticipated[41]. - The company has no significant contingent liabilities as of June 30, 2022, consistent with the previous year[131]. Other Information - The company did not recommend an interim dividend for the six months ended June 30, 2022, to retain capital for operational needs and potential investment opportunities[9]. - The company did not engage in any purchases, sales, or redemptions of its listed securities during the six-month period[67]. - There were no significant events after the reporting period, indicating stability in operations[66]. - The company has not raised any bank financing during the review period, relying solely on its available funds for operations[38].
中国创新投资(01217) - 2021 - 年度财报
2022-03-30 09:31
Financial Performance - The total proceeds from investment sales for the year ended December 31, 2021, amounted to approximately HKD 544,048,000, compared to HKD 369,878,000 for the year ended December 31, 2020, representing a year-over-year increase of 47%[11]. - The net loss attributable to shareholders for the year ended December 31, 2021, was approximately HKD 33,923,000, compared to a loss of HKD 9,813,000 in the same period of 2020, indicating a significant increase in losses[20]. - As of December 31, 2021, the net asset value of the company was approximately HKD 611,002,000, down from HKD 653,748,000 in 2020, with a net asset value per share of HKD 0.05, unchanged from the previous year[20]. - The company recorded a net realized loss of approximately HKD 52,751,000 from investments measured at fair value through profit or loss for the year ended December 31, 2021, compared to a net gain of HKD 15,657,000 in the previous year[20]. - The company's distributable reserves as of December 31, 2021, were approximately HKD 482,986,000, a decrease from HKD 525,732,000 in 2020[134]. - The company did not declare any dividends for the year, consistent with the previous year[130]. - The company has a cash and bank balance of approximately HKD 13,381,000 as of December 31, 2021, with a zero debt-to-equity ratio[38]. Investment Strategy - The company is actively seeking profitable investment opportunities in energy-saving and emission-reduction sectors to build a complete industrial chain[15]. - The company plans to continue exploring investment opportunities to achieve mid-term capital appreciation[16]. - The company has invested in various sectors, including renewable energy, new materials, and health communication products, aiming for breakthroughs in five key industries[12][14]. - The company's primary investment strategy focuses on investing in quality listed and unlisted companies in Hong Kong and China, aiming for mid-term capital appreciation[54]. - The company aims to balance risks by investing in various sectors, including IT, telecommunications, manufacturing, and life sciences[54]. - The company may seek to invest in companies with strong growth potential and solid management, particularly those with advanced technology and R&D capabilities[54]. Market and Economic Outlook - The company maintains a cautious outlook on the securities market due to ongoing uncertainties from the COVID-19 pandemic and the US-China trade war[21]. - The company anticipates that its investment projects, primarily operating in China, will be affected by the economic recovery signs in China in 2021[51]. - The company faces economic risks due to its investments being significantly influenced by the macroeconomic development in China[58]. - The company is experiencing increased competition in the private equity investment market, leading to challenges in securing potential investment targets[59]. - The company is subject to market risks, with stock prices influenced by macroeconomic factors, potentially affecting the value of its listed stock holdings and net asset value[63]. Corporate Governance - The board of directors consists of two executive directors, one non-executive director, and three independent non-executive directors, ensuring governance and oversight of the company's operations[76]. - The company adheres to corporate governance standards, although there are deviations regarding the roles of the chairman and CEO, which are held by the same individual[70]. - The board has a high attendance rate at meetings, indicating active participation in governance and decision-making processes[78]. - The company is committed to maintaining high levels of corporate governance to protect shareholder interests and ensure transparency[69]. - The company has established a board diversity policy to ensure a balanced mix of skills, experience, and diversity among board members[83]. Risk Management - The board of directors is responsible for the overall risk management and internal control systems to protect the interests of the company and its shareholders[110]. - The audit committee reports to the board and is empowered to continuously monitor and assess the effectiveness of relevant systems[111]. - The company has implemented an internal compliance officer position to enhance internal controls, which operates independently from the business operations[98]. - The board has reviewed the effectiveness of the internal control system and deemed it robust enough to protect shareholder and employee interests[97]. Environmental and Social Responsibility - The company is committed to environmental and social sustainability, ensuring compliance with environmental laws and regulations[118]. - The company has identified key ESG issues, including environmental impact control, employment practices, and management responsibility[169]. - The company is committed to reducing carbon emissions and enhancing resource efficiency in its operations[174]. - The company encourages employees to use digital communication methods to minimize business travel[175]. - The company has implemented a "green" office standard to promote environmental sustainability[175]. - The company collaborates with suppliers for recycling materials or donating non-reusable IT equipment to non-profit organizations[189]. Employee and Compensation - The total employee compensation for the year was approximately HKD 1,413,000, a decrease from HKD 1,698,000 in the previous year[42]. - The company has established a mandatory provident fund retirement benefits plan for all its Hong Kong employees, with contributions based on a percentage of employees' basic salaries[160]. - The company maintained a workforce of 27 employees as of December 31, 2021, consistent with the previous year[197]. - The gender ratio within the company is approximately 2:1, promoting diversity in the workforce[197]. Audit and Compliance - The total audit fees paid to the external auditor for the year amounted to HKD 290,000[102]. - The audit committee has confirmed the independence of the external auditor, Long Green (Hong Kong) CPA Limited, and recommended their reappointment at the upcoming annual general meeting[99]. - The company has committed to preparing financial statements in accordance with the Hong Kong Financial Reporting Standards[101]. Shareholder Communication - The company maintains continuous communication with shareholders through various channels, including its website, where announcements and reports are published[112]. - The company has a dedicated website for investor relations, providing updates on business developments and operational information[116]. - The independent non-executive directors are required to attend the annual general meeting to understand shareholders' opinions fairly[114].
中国创新投资(01217) - 2021 - 中期财报
2021-08-24 07:08
CHINA INNOVATION INVESTMENT LIMITED 中國創新投資有限公司 (股份代號: 1217) (於開曼群島註冊成立之有限公司) 2021 中期報告 頁次 公司資料2 財務摘要3 管理層討論及分析4 權益披露11 企業管治及其他資料13 簡明損益及其他全面收益表16 簡明財務狀況表17 簡明權益變動表18 簡明現金流量表19 簡明財務報表附註20 中國創新投資有限公司 中期報告 2021 1 目錄 中國創新投資有限公司 中期報告 2021 2 | --- | --- | |-----------------------------------------------------|--------------------------------------------------------| | | | | 公司資料 | 主要營業地點 | | 執行董事 | 香港上環 | | 向心先生 (主席兼行政總裁) | 德輔道西 9 號 26 樓 | | 陳昌義先生 | 主要股份過戶登記處及過戶處 | | 獨立非執行董事 | Suntera (Cayman) Limited | | 安靜女士 | ...
中国创新投资(01217) - 2020 - 年度财报
2021-03-30 08:38
in the 1 0 0 1 0 0 0 0 1 1 1 1 0 11:1 - 0 0 0 0 1 0 | --- | --- | --- | --- | --- | |-------------------------------------------------------------------------------------------|-------|-------|-------|-------| | | | | | | | 3 | | | | | | | | | | | | | | | | | | | | | | | | CHINA INNOVATION INVESTMENT LIMITED 中國創新投資有限公司 : (於朗曼群島註冊成立之有限公司) | | | | | | (股份代號: 1217) 年報 2020 | | | | | | | | | | | | - 0 0 -0 0 :1:0: -0 | | | | | | 1 1 1 1 -1 :1 1 0 D 0 0 1 | | | | | 0 0 0 1 C 1 1 1 1 0 1 c 0 0 0 0 0- 0 1 1 0 1 0 ...
中国创新投资(01217) - 2020 - 中期财报
2020-08-25 09:46
CHINA INNOVATION INVESTMENT LIMITED 2020 中期報告 中國創新投資有限公司 (股份代號: 1217) (於開曼群島註冊成立之有限公司 ) 頁次 公司資料2 財務摘要3 管理層討論及分析4 權益披露11 企業管治及其他資料13 簡明損益及其他全面收益表18 中國創新投資有限公司 中期報告 2020 1 目錄 簡明財務狀況表 簡明權益變動表 簡明現金流量表 簡明財務報表附註 19 20 21 22 中國創新投資有限公司 中期報告 2020 2 | --- | --- | |---------------------------------------------------|-------------------------------------------------------------| | | | | 公司資料 | 主要營業地點 香港上環 | | 執行董事 | 德輔道西 9 號 26 樓 | | 向心先生 (主席兼行政總裁) | | | 陳昌義先生 | 主要股份過戶登記處及過戶處 | | 獨立非執行董事 | Royal Bank of CanadaTrust Co ...
中国创新投资(01217) - 2019 - 年度财报
2020-03-31 08:54
2019 年報 | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |------------------------------------------------------------------------|-------|-------|-------|-------|-------------------|-------|-------|-------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ...
中国创新投资(01217) - 2019 - 中期财报
2019-08-27 08:56
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------|-------|-------|-------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | CHINA INNOVATION INVESTMENT LIMITED 中國創新投資有限公司 (於爾曼群島註冊成立之有限公司) (股份代號: 1217) 中國創新投資有限公司 中期報告2019 目錄 頁次 公司資料2 財務摘要3 管理層討論及分析4 權益披露8 企業管治及其他資料10 簡明損益及其他全面收益表13 簡明財務狀況表14 簡明權益變動表15 簡明現金流量表16 簡明財務報表附註17 1 中國創新投資有限公司 中期報告2019 2 www.1217.com.hk | --- | --- | |--------------------------------------------------|------------------- ...
中国创新投资(01217) - 2018 - 年度财报
2019-04-11 09:28
China Innovation Investment Limited 中國創新投資有限公司 ANNUAL R E P ORT 年 報 2018 2018 CHINA INNOVATION INVESTMENT LIMITED 中國創新投資有限公司 Annual Report 2018 年報 (Incorporated in the Cayman Islands with limited liability) (Stock Code: 1217) CHINA INNOVATION INVESTMENT LIMITED 中國創新投資有限公司 (於開曼群島註冊成立之有限公司) (股份代 號 :1217) 目錄 公司資料2 主席致辭3 管理層討論及分析5 企業管治報告8 董事簡歷 16 董事局報告 18 環境、社會及管治報告 24 獨立核數師報告 31 損益及其他全面收益表 35 財務狀況表 36 權益變動表 37 現金流量表 38 財務報表附註 39 五年財務概要 74 公司資料 | --- | --- | |---------------------------------------------------- ...